Skin sterol study
This article was originally published in The Tan Sheet
People with high levels of skin tissue cholesterol and C-reactive protein have nearly double the risk of metabolic syndrome compared to those without elevated levels of both markers, according to data presented by PreMD at the American Heart Association's Annual Arteriosclerosis, Thrombosis & Vascular Biology conference in Toronto April 27. The study used PREVU* Point Of Care Skin Sterol Test to measure skin sterol and C-reactive protein levels in 301 patients with established coronary artery disease to assess whether the two markers could help predict metabolic syndrome. "The prevalence of metabolic syndrome in was significantly higher in patients who scored highest for both skin sterol and C-reactive protein, and remained significant after adjustment for age and gender, compared to isolated elevators of either marker alone," Milan Gupta, MD, McMaster University, Ontario, et al., state. PreMD is currently investigating a home-use version of the PREVU* test, which is currently designed for use by medical professionals. However, the home-use product has not yet entered the clinical stage, a spokesperson says...
You may also be interested in...
AstraZeneca's CEO and other leaders from COVID-19 vaccine companies will face some tough questions in Brussels, but the European Commission wants to put differences behind it and solve the vaccine supply problem as soon as possible.
Abingdon Health has announced that a study run in conjunction with the UK Rapid Test Consortium has demonstrated that its AbC-19 test could be an effective tool for testing vaccine efficacy.
NGO says the Expert Panel for Cosmetic Ingredient Safety’s conclusion on methylisothiazolinone in 2020 was among decisions “not in the interest of public health.” However, other assessments highlighted by the group suggest that the Cosmetic Ingredient Review is working as an open forum for public input and discussion.